Sotera Health Co. (NASDAQ: SHC) reported Q3 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $263 million versus the consensus estimate of $264.55 million.

2023 Outlook

Based on ongoing market softness, Sotera Health anticipates 2023 results will be at the lower end of its previously announced outlook on August 3, 2023. That outlook is:

Net revenues in the range of $1.035 to $1.055 billion,versus the consensus of $1.047 billion representing growth of approximately 3% to 5%, compared to the prior year,
Adjusted EBITDA in the range of $520 to $535 million, representing growth of approximately 3% to 6%, compared to the prior year,
The tax rate applicable to Adjusted Net Income in the range of 30% to 32%,
Adjusted EPS in the range of $0.78 to $0.86,
A fully diluted share count remains in the range of 283 million to 285 million shares on a weighted-average basis,
Capital expenditures in the range of $200 to $215 million, and
2023 year-end Net Leverage Ratio expected to end the year at or below 4.0x.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.